Breast Cancer Risk for Women With a TP53 Pathogenic Variant Reply

被引：0
|
作者：
Fortuno, Cristina [1 ]
Spurdle, Amanda B. [1 ]
James, Paul A. [2 ,3 ]
机构：
[1] QIMR Berghofer Med Res Inst, Populat Hlth Program, Brisbane, Qld, Australia
[2] Peter MacCallum Canc Ctr, Parkville Familial Canc Ctr, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
JCO PRECISION ONCOLOGY | 2024年 / 8卷
关键词：
D O I：
10.1200/PO.24.00270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] TP53 haplotypes and susceptibility to breast cancer.
    Kristensen, Vessela
    Garcia-Closas, Montserrat
    Langerod, Anita
    Qi, Ying
    Yeager, Meredith
    Burdett, Laurie
    Welch, Robert
    Lissowska, Jolanta
    Peplonska, Beata
    Bardin-Mikolajczak, Alicija
    Brinton, Louise
    Gerhard, Daniela S.
    Perou, Charles
    Borresen-Dale, Anne-Lise
    Chanock, Stephen
    CANCER RESEARCH, 2006, 66 (08)
  • [32] TP53 Mutation Patterns in Breast Cancer Subgroups
    Dumay, A.
    Feugeas, J-P
    Wittmer, E.
    Lehmann-Che, J.
    Bertheau, P.
    Espie, M.
    de Cremoux, P.
    Andre, F.
    Sotiriou, C.
    Pusztai, L.
    de The, H.
    CANCER RESEARCH, 2011, 71
  • [33] THE ROLE OF TP53 IN BREAST-CANCER DEVELOPMENT
    EELES, RA
    BARTKOVA, J
    LANE, DP
    BARTEK, J
    CANCER SURVEYS, 1993, 18 : 57 - 75
  • [34] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [35] TP53 status and response to chemotherapy in breast cancer
    Bertheau, Philippe
    Espie, Marc
    Turpin, Elisabeth
    Lehmann, Jacqueline
    Plassa, Louis-Francois
    Varna, Mariana
    Janin, Anne
    de The, Hugues
    PATHOBIOLOGY, 2008, 75 (02) : 132 - 139
  • [36] A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA
    Gemignani, F
    Moreno, V
    Landi, S
    Moullan, N
    Chabrier, A
    Gutiérrez-Enríquez, S
    Hall, J
    Guino, E
    Peinado, MA
    Capella, G
    Canzian, F
    ONCOGENE, 2004, 23 (10) : 1954 - 1956
  • [37] TP53 mutation in triple negative breast cancer
    Nikolaidou, A.
    Botsfari, E.
    Goupou, E.
    Rouptsiou, E.
    Iosifidou, R.
    Patakiouta, F.
    VIRCHOWS ARCHIV, 2017, 471 : S302 - S302
  • [38] TP53 as a predictor of response to chemotherapy in breast cancer
    Lonning, PE
    Johnsen, H
    Geisler, S
    Aas, T
    Smith-Sorensen, B
    Akslen, LA
    Borresen-Dale, AL
    PRIMARY MEDICAL THERAPY FOR BREAST CANCER: CLINICAL AND BIOLOGIC AL ASPECTS, 1999, 4 : 73 - 88
  • [39] A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA
    Federica Gemignani
    Victor Moreno
    Stefano Landi
    Norman Moullan
    Amélie Chabrier
    Sara Gutiérrez-Enríquez
    Janet Hall
    Elisabeth Guino
    Miguel Angel Peinado
    Gabriel Capella
    Federico Canzian
    Oncogene, 2004, 23 : 1954 - 1956
  • [40] Evaluating Computational Predictions of TP53 Variant Function by Correlating with Survival Data in Breast Cancer
    Coleman, J.
    Miller, C.
    Jones, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1044 - 1044
12345